Rosemary Jose is Executive Director, Strategic Market Access at OPEN Health. With an experience of over 17 years across the pharma industry in both global and consulting roles, her main areas of focus are payer value communication, EU HTA joint clinical assessments, market access strategy, cross-functional evidence generation plans and regional trainings/workshops.

Rosemary has >16 years of experience across the pharmaceutical industry, including >14 years in market access and health economics, both in global and consulting roles – leading strategic projects, managing international clients and mentoring multi-cultural teams. She has also provided on-site support to pharmaceutical clients in Europe, driving the market access strategy through cross-functional collaboration, to facilitate launch and reimbursement. Her experience covers multiple therapeutic areas including oncology, neurosciences, ophthalmology, infections and immunology, gastroenterology and cardiovascular medicine. Rosemary holds a PhD in Pharmacogenetics, and certifications in HTA and Market Access.